[ad_1]
The massive amount of buzz surrounding Christopher Nolan’s latest project, Oppenheimer, differentiates the movie from typical Hollywood biopics.
The massive amount of buzz surrounding Christopher Nolan’s latest project, Oppenheimer, is breaking a typical Hollywood biopic trend. Based on the life of the man known as the “father of the atomic bomb“, Oppenheimer chronicles the life of controversial theoretical physicist J. Robert Oppenheimer (Cillian Murphy) a leading figure in the infamous Manhattan Project during the Second World War. However, the film expands well beyond Oppenheimer’s most famous invention, with it also focusing on his affiliation with the Communist Party and the subsequent investigation into his loyalty during the Red Scare in the 1950s.
Cillian Murphy stars alongside a truly remarkable ensemble cast, including Emily Blunt as Oppenheimer’s wife, and Communist, Kitty Oppenheimer; Robert Downey Jr. as Lewis Strauss, the US Secretary of Commerce and a major figure within the development of nuclear weapons; and Matt Damon as Lieutenant General Leslie Groves, the director of the Manhattan Project itself. However, Oppenheimer‘s incredible cast is only one reason for the hype surrounding Nolan’s latest project, which differentiates the film from the litany of other biopics.
Why Oppenheimer Is Different From Usual Movie Biopics
Oppenheimer is different from usual movie biopics due to the massive amount of buzz surrounding the film. It is incredibly rare for biopics to receive a true blockbuster-like reception from audiences, especially before release. Oppenheimer, which is budgeted at an eye-watering $100 million, has a summer 2023 release date, a time of year typically reserved for superhero and action movies. In fact, Oppenheimer‘s July release is flanked by Tom Cruise’s highly-anticipated Mission: Impossible – Dead Reckoning – Part One and the 33rd entry in the MCU, The Marvels. The combination of this enormous budget and summer release shows that Universal Pictures has blockbuster-like ambitions for Oppenheimer when it comes to ticket sales.
Unlike Oppenheimer, Nolan’s return after 2020’s Tenet, biopics usually have a winter release date, typically to utilize award nominations to build up hype. For example, the sports biopic about the father of tennis players Serena and Venus Williams, King Richard, was released in November 2021. It also had a significantly lower budget than Oppenheimer, at a mere $50 million, much of which went to star Will Smith. This shows that both director Christopher Nolan and studio Universal Pictures have incredible ambitions for Oppenheimer, outside the typical award buzz that most biopics rely on to attract large audiences.
Oppenheimer’s Hype Is Both A Blessing & A Curse
While a massive amount of hype is typically seen as a blessing for a blockbuster like Oppenheimer, it can also be a curse. With Oppenheimer, Christopher Nolan is returning to theaters for the first time since his spectacular box office bomb, Tenet. Although much of Tenet‘s box office failures can be attributed to its summer 2020 release date, during the height of the ongoing COVID pandemic, its mixed reviews cannot be. Tenet was heavily criticized for its confusing story and often unintelligible dialogue due to its immersive but incredibly controversial sound mixing.
Should Oppenheimer not receive the critical acclaim and blockbuster-level ticket sales that Universal is clearly hoping for, then Oppenheimer could place Nolan’s career in jeopardy as it would be his second high-profile financial bomb in a row. This means that alongside the vast amount of hype that Oppenheimer has, there is incredible pressure for it to be financially successful. However, the hype surrounding Christopher Nolan’s explosive Oppenheimer should help it to deliver the blockbuster success that Universal Pictures and the director himself are hoping for, differentiating the film from typical Hollywood biopics.
Key Release Dates
[ad_2]
Source link
Armessa Movie News